SAGILITY LIMITED CC-Dec24.pdf · 2025-02-05
Yes. I have three questions. I'll just ask all of them. So firstly, I was just looking at the earnings of couple of your large clients. They seem to be talking about medical costs continuing to go up and probably 2025 also being a repeat of 2024. So if you could comment on how that impacts your business opportunities both positively and negatively? Secondly, in terms of the acquisition, the synergies that you have mentioned in your presentation highlight largely cross sell and probably the addition of a new capability. But you have not talked about offshoring given the high on -site presence of this w orkforce. So is that something that is not likely to play out? And the third one would be the margin guidance that you have given 24% to 25%. This is excluding other income, and the two adjustments are largely the ones that are in the presentation, the share based awards and the acquisition payouts. Those were the three questiions. Thank you.
Okay. I just have one quick follow -up to the first question, you would classify that as a net positive or largely a neutral event, the medical cost going on?